Optometrist · Lafayette, IN
NPI
1427165893
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1400 Teal Rd Ste 8
Lafayette, IN, 47905
Phone (317) 841-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$356K
6,121 services
Medicare patients, 2024
1,150
Average age 76
Drug cost, 2024
$2.2M
2,436 prescriptions
Company payments, 2025
$3,128
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen W Kimmell was code 83861 (clinical chemistry), 1,496 times for 535 patients. In total Stephen W Kimmell billed 6,121 services in 30 codes, and Medicare paid $356K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83861 Clinical Chemistry | Office | 1,496 | 535 | $21.90 | $33K |
| 92136 Ultrasound - Nonspecific | Office | 854 | 434 | $28.78 | $25K |
| 99214 Office E&M - Established | Office | 788 | 460 | $88.13 | $69K |
| 99213 Office E&M - Established | Office | 487 | 360 | $66.07 | $32K |
| 99204 Office E&M - New | Office | 463 | 462 | $109.44 | $51K |
| 92133 Computerized Ophthalmic Imaging | Office | 447 | 306 | $24.36 | $11K |
| 83516 Immunoassay | Office | 392 | 152 | $11.24 | $4,407 |
| 92134 Computerized Ophthalmic Imaging | Office | 317 | 301 | $27.33 | $8,664 |
| 92083 Vision, Hearing, and Speech Services | Office | 305 | 283 | $44.19 | $13K |
| 92014 Ophthalmological E&M | Office | 198 | 192 | $74.32 | $15K |
| 65778 Eye | Office | 97 | 58 | $834.32 | $81K |
| 92004 Ophthalmological E&M | Office | 88 | 88 | $90.01 | $7,921 |
| 76514 Ultrasound - Nonspecific | Office | 65 | 62 | $6.91 | $449 |
| 92025 Test - Miscellaneous | Office | 47 | 46 | $24.88 | $1,169 |
| 99203 Office E&M - New | Office | 22 | 22 | $68.17 | $1,500 |
By year: 2022 $299K for 4,977 services; 2023 $355K for 5,393 services; 2024 $356K for 6,121 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 1,496 | 535 | $21.90 | $33K |
| 83516 Immunoassay | 392 | 152 | $11.24 | $4,407 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen W Kimmell prescribed most often to Medicare patients was Latanoprost, with 508 prescriptions and refills. In total Stephen W Kimmell wrote 2,436 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 508 | 1,092 | 165 | $6,223 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 223 | 482 | 67 | $3,989 |
| Brimonidine Tartrate Generic | 199 | 380 | 66 | $2,898 |
| Xdemvy Lotilaner | 190 | 297 | 188 | $350K |
| Prednisolone Acetate Generic | 173 | 262 | 133 | $6,898 |
| Dorzolamide Hcl Generic | 131 | 269 | 44 | $2,348 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 129 | 160 | 28 | $53K |
| Restasis Cyclosporine | 120 | 205 | 56 | $124K |
| Timolol Maleate Generic | 120 | 317 | 51 | $1,067 |
| Lumigan Bimatoprost | 97 | 196 | 35 | $51K |
| Xiidra Lifitegrast | 63 | 119 | 38 | $81K |
| Vevye Cyclosporine | 45 | 45 | 13 | $33K |
| Cyclosporine Generic | 34 | 78 | 23 | $18K |
| Vyzulta Latanoprostene Bunod | 31 | 53 | Under 11 | $14K |
| Ketorolac Tromethamine Generic | 27 | 37 | 20 | $723 |
Brand drugs: 1,126 claims; generic drugs: 1,310 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen W Kimmell $3,128 ($3,128 in general payments such as food, travel and fees) from 14 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $1,416.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $1,416 |
| Tarsus Pharmaceuticals, Inc. TARS | 12 | $423 |
| Dompe US, Inc. | 7 | $287 |
| Alcon Vision LLC ALC | 7 | $275 |
| Mallinckrodt Hospital Products Inc. | 5 | $216 |
| RxSight Inc RXST | 3 | $149 |
| Abbvie Inc. ABBV | 4 | $91.06 |
| Biotissue Holdings Inc. | 3 | $83 |
| Glaukos Corporation GKOS | 1 | $50.61 |
| Harrow Eye, LLC | 2 | $48.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.